CureVac N.V. (5CV.F)
EUR 2.72
(-2.01%)
EUR 2.72
(-2.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 53.75 Million | 67.42 Million | 102.99 Million | 48.9 Million | 17.41 Million | 12.87 Million |
| Cost of Revenue | 124.36 Million | 183.99 Million | 238.19 Million | 14.17 Million | 27.98 Million | 17.74 Million |
| Gross Profit | -70.6 Million | -116.57 Million | -135.2 Million | 34.72 Million | -10.56 Million | -4.87 Million |
| Operating Expenses | 211.75 Million | 134.27 Million | 277.05 Million | 158.7 Million | 88.93 Million | 67.95 Million |
| Selling, General and Administrative Expenses | 76.43 Million | 89.41 Million | 88.94 Million | 45.76 Million | 43.93 Million | 21.5 Million |
| Research and Development Expenses | 115.72 Million | 62.55 Million | 815.9 Million | 113.8 Million | 43.24 Million | 41.72 Million |
| Other Expenses | 11.44 Million | -17.68 Million | -627.79 Million | -870 Thousand | 1.75 Million | 4.72 Million |
| Cost and Expenses | 327.96 Million | 318.27 Million | 515.25 Million | 158.7 Million | 116.91 Million | 85.69 Million |
| Operating Income | -274.2 Million | -249.45 Million | -412.26 Million | -124 Million | -99.49 Million | -72.82 Million |
| Interest Expense | 2.49 Million | 3.7 Million | 10.33 Million | 22.1 Million | 1.46 Million | 275 Thousand |
| Income Tax Expense | 198 Thousand | -126 Thousand | -782 Thousand | -726 Thousand | -252 Thousand | 110 Thousand |
| Earnings before Tax | -259.96 Million | -249.15 Million | -412.49 Million | -129.8 Million | -100.12 Million | -71.13 Million |
| Net Income | -260.16 Million | -249.02 Million | -411.71 Million | -129.07 Million | -99.87 Million | -71.24 Million |
| Earnings Per Share Basic | -1.18 | -1.32 | -2.21 | -0.98 | -0.53 | -0.40 |
| Earnings Per Share Diluted | -1.18 | -1.32 | -2.21 | -0.98 | -0.53 | -0.40 |
| Weighted Average Shares Outstanding | 220.48 Million | 189.07 Million | 186.01 Million | 132.19 Million | 186.91 Million | 175.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 220.83 Million | 189.07 Million | 186.01 Million | 132.19 Million | 186.91 Million | 175.96 Million |
| Gross Margin | -1.31 | -1.73 | -1.31 | 0.71 | -0.61 | -0.38 |
| EBIT Margin | -4.35 | -3.31 | -3.75 | -2.25 | -5.25 | -5.21 |
| Profit Margin | -4.84 | -3.69 | -4.00 | -2.64 | -5.73 | -5.54 |
| EBITDA | -234.09 Million | -209.38 Million | -386.48 Million | -123.09 Million | -91.5 Million | -69.85 Million |
| Earnings Before Tax Margin | -5.10 | -3.70 | -4.00 | -2.54 | -5.71 | -5.66 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.5 Million | 12.37 Million | 52.65 Million | 21.98 Million | 16.48 Million | 7.57 Million |
| Cost of Revenue | 45.73 Million | 41.68 Million | 143.73 Million | 59.76 Million | 24.28 Million | 25.85 Million |
| Gross Profit | -31.22 Million | -29.31 Million | -91.07 Million | -37.77 Million | -7.79 Million | -18.27 Million |
| Operating Expenses | 43.46 Million | 44.92 Million | 185.14 Million | 52.62 Million | 46.71 Million | 53.7 Million |
| Selling, General and Administrative Expenses | 14.78 Million | 16.79 Million | - | 23.25 Million | 15.98 Million | 19.06 Million |
| Research and Development Expenses | 28.68 Million | 27.82 Million | - | 29.37 Million | 27.24 Million | 30.86 Million |
| Other Expenses | -855 Thousand | - | -1.00 | - | - | - |
| Cost and Expenses | 89.19 Million | 86.61 Million | 328.87 Million | 112.38 Million | 70.99 Million | 79.55 Million |
| Operating Income | -74.68 Million | -73.31 Million | -276.22 Million | -90.4 Million | -54.03 Million | -71.8 Million |
| Interest Expense | 155 Thousand | 340 Thousand | 2.49 Million | -4.32 Million | 4.08 Million | 1.78 Million |
| Income Tax Expense | 1.3 Million | 666 Thousand | 193.94 Thousand | 160.76 Thousand | 6000.00 | 26 Thousand |
| Earnings before Tax | -71.6 Million | -69.88 Million | -254.64 Million | -84.26 Million | -48.67 Million | -67.38 Million |
| Net Income | -72.9 Million | -70.55 Million | -254.83 Million | -84.42 Million | -48.68 Million | -67.41 Million |
| Earnings Per Share Basic | -0.33 | -0.31 | - | -0.38 | -0.22 | -0.30 |
| Earnings Per Share Diluted | -0.33 | -0.31 | - | -0.38 | -0.22 | -0.30 |
| Weighted Average Shares Outstanding | 224.31 Million | 224.29 Million | 220.83 Million | 223.98 Million | 223.91 Million | 223.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 224.31 Million | 224.29 Million | 220.83 Million | 223.98 Million | 223.91 Million | 223.88 Million |
| Gross Margin | -2.15 | -2.37 | -1.73 | -1.72 | -0.47 | -2.41 |
| EBIT Margin | -4.74 | -5.30 | - | -3.70 | -2.38 | -7.94 |
| Profit Margin | -5.03 | -5.70 | -4.84 | -3.84 | -2.95 | -8.89 |
| EBITDA | -68.8 Million | -65.6 Million | - | -81.32 Million | -39.15 Million | -60.14 Million |
| Earnings Before Tax Margin | -5.15 | -5.93 | -5.25 | -4.11 | -3.28 | -9.47 |
AREA
BONXF
0H9N
IFPJF
CDDRF
SASKEN